
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.870 | 3.870 | 0.000 |
Shares | 96.170 | 96.170 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.160 | 18.829 |
Price to Book | 6.714 | 3.133 |
Price to Sales | 4.746 | 2.249 |
Price to Cash Flow | 17.646 | 12.421 |
Dividend Yield | 1.279 | 2.067 |
5 Years Earnings Growth | 10.295 | 9.908 |
Name | Net % | Category Average |
---|---|---|
Technology | 41.680 | 20.255 |
Healthcare | 40.550 | 12.682 |
Communication Services | 17.770 | 9.747 |
Number of long holdings: 33
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 9.08 | 202.38 | -2.50% | |
NVIDIA | US67066G1040 | 7.55 | 173.72 | -2.33% | |
Microsoft | US5949181045 | 7.38 | 524.11 | -1.76% | |
Alphabet A | US02079K3059 | 7.11 | 189.13 | -1.44% | |
Meta Platforms | US30303M1027 | 5.76 | 749.82 | -3.05% | |
Eli Lilly | US5324571083 | 5.48 | 762.65 | +3.05% | |
UnitedHealth | US91324P1021 | 5.32 | 237.65 | -4.77% | |
Roche Holding Participation | CH0012032048 | 5.08 | 257.10 | -0.96% | |
Novartis | CH0012005267 | 4.80 | 94.19 | -0.87% | |
Thermo Fisher Scientific | US8835561023 | 3.93 | 463.04 | -0.99% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Renaissance Global Growth CAD | 5.02B | -0.27 | 13.82 | 9.19 | ||
Renaissance Global Growth Cl F CAD | 5.02B | 0.37 | 15.30 | 10.62 | ||
Renaissance International Eq CAD | 1.75B | 2.20 | 9.34 | 5.88 | ||
Renaissance International Eq Cl CAD | 1.75B | 2.85 | 10.75 | 7.29 | ||
Renaissance US Equity Income F CAD | 1.51B | -1.99 | 9.58 | 9.35 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review